Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Buy | Neutral |
| Technical Indicators | Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 118.14 | 120.86 | 117.83 | -0.08 | -0.07% | 16.58M | NASDAQ | |||
| 166.97 | 170.99 | 166.43 | +0.84 | +0.51% | 2.80M | NYSE | |||
| 0.286 | 0.298 | 0.275 | +0.004 | +1.38% | 3.54M | NASDAQ | |||
| 141.17 | 146.02 | 138.60 | +2.61 | +1.88% | 625.93K | NASDAQ | |||
| 16.00 | 17.26 | 15.97 | -0.06 | -0.37% | 12.42M | NYSE | |||
| 71.48 | 72.06 | 71.48 | +1.40 | +2.00% | 36.06K | OTC Markets | |||
| 49.26 | 51.18 | 48.91 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 49.57 | 49.81 | 48.94 | +0.30 | +0.61% | 14.99M | NYSE | |||
| 30.58 | 31.52 | 30.15 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 25.79 | 26.20 | 25.44 | -0.07 | -0.27% | 71.94K | NASDAQ | |||
| 353.22 | 362.23 | 351.40 | -2.71 | -0.76% | 643.70K | NYSE | |||
| 99.65 | 100.12 | 98.14 | +2.43 | +2.50% | 1.33M | NYSE | |||
| 10.75 | 10.99 | 10.41 | +0.08 | +0.75% | 103.83K | OTC Markets | |||
| 21.13 | 21.60 | 20.03 | +0.62 | +3.00% | 113.80K | OTC Markets | |||
| 15.14 | 15.23 | 14.88 | +0.91 | +6.39% | 3.93M | OTC Markets |